The International Agency for Research on Cancer found that approximately 14.1 million cancer cases were diagnosed in 2012 and is expected to reach 21.7 million by 2030 across the world. This shows that the demand for therapeutics biologics is likely to increase, further propelling demand for virus filtration products. Spurred by this, the global virus filtration market is expected to grow in the forthcoming years. The adoption of virus filtration technology is likely to increase, mainly for the purification of biopharmaceutical products. The demand for virus filtration system is likely to increase owing to the rising chances of viral contamination, encountered while conducting research. Some of the viruses include mouse minute virus, reovirus, and cache valley virus lead to viral contamination in biopharmaceuticals products. Rising preference towards biologics and FDA approvals on biologics products are factors responsible for the positively impacting the biologics segment application. Among other applications, biologics are expected to hold the major part of the virus filtration market share.
India’s Biopharmaceutical Industry to Cross US$ 100 Billion by 2025, Driving the Market in Asia Pacific
North America is projected to maintain its dominance in the global virus filtration market through the forecast years. The increasing adoption of virus filtration products in biopharmaceutical and medical sectors is the primary factor driving the market in this region. Europe is anticipated to create huge growth opportunities for the virus filtration market on account of the rising number of research activities.
As per the Indian Brand Equity Foundation, the biopharmaceutical industry in India is projected to reach US$ 100 billion by 2025. Considering this, the demand for virus filters is expected to surge, thereby impacting the virus filtration market size in Asia Pacific. Furthermore, the adoption of virus filtration technology is likely to increase owing to the rising improvements in healthcare infrastructure.
Pall Corporation to Launch a New Business Unit New to Strengthen its Market Position
The report highlights in-depth analysis of leading companies operating in the global virus filtration market. Some of the big players are mentioned below:
- Asahi Kasei Medical Co. Ltd.
- General Electric Company
- Danaher Corporation
- Sartorius AG
- Clean Cell Inc.
- Wuxi Biologics
- Thermo Fischer Scientific Inc.
- Lonza Group Ltd
- Charles River Laboratories International Inc
More Trending Topics From Fortune Business [email protected]